Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from SS Innovations International ( (SSII) ) is now available.
On March 18, 2026, SS Innovations International announced that its SSi Mantra surgical robotic system has been approved for telesurgeries in Indonesia and the Philippines, marking an expansion beyond its primary base in India. The company also disclosed that more than 150 cumulative telesurgeries have now been successfully completed using the platform, underscoring growing clinical adoption of its remote-surgery capabilities.
Recent milestones included 18 inter-hospital telesurgeries completed between Indore and Bhopal in India over eight hours on February 14, 2026, as well as a December 23, 2025 telesurgery marathon in which nine surgeons performed 24 procedures, including intricate cardiac operations. These events highlight the practical scalability of the SSi Mantra system and its compact MantrAsana Tele Surgeon Console, which is designed to enable remote procedures from varied settings.
The company also announced it will host the Global Multi-Specialty Robotic Surgery Conference 2026 in New Delhi from April 9-11, 2026, where more than 20 live telesurgeries using SSi Mantra are planned across multiple specialties. By coupling regulatory approvals in new Asian markets with high-profile clinical demonstrations and an international conference, SS Innovations is seeking to strengthen its position in robotic telesurgery and broaden access to advanced surgical care in emerging markets.
The most recent analyst rating on (SSII) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.
Spark’s Take on SSII Stock
According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.
The score is mainly constrained by weak financial quality—persistent losses and increasing cash burn—despite strong revenue momentum and a strengthened balance sheet. Technicals are neutral-to-mixed with longer-term trend pressure, while recent corporate events (financing, debt elimination, expansion and regulatory progress) provide a modest offset.
To see Spark’s full report on SSII stock, click here.
More about SS Innovations International
SS Innovations International, Inc. is a surgical robotics company that develops technologies aimed at making robotic surgery more affordable and accessible globally. Its portfolio includes the proprietary SSi Mantra surgical robotic system and the SSi Mudra suite of instruments, which support a wide range of procedures, including cardiac surgery, with a focus on technologically advanced, user-friendly and cost-effective solutions.
Average Trading Volume: 98,140
Technical Sentiment Signal: Sell
Current Market Cap: $923.2M
For detailed information about SSII stock, go to TipRanks’ Stock Analysis page.